Mirum Pharmaceuticals
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $99,414 | $90,377 | $77,875 | $69,222 |
Gross Profit | 76,634 | 69,571 | 57,648 | 51,392 |
EBITDA | -14,731 | -4,247 | -14,580 | -15,414 |
EBIT | -20,787 | -10,302 | -20,434 | -21,078 |
Net Income | -23,790 | -14,235 | -24,638 | -25,279 |
Net Change In Cash | 99,414 | 90,377 | 77,875 | 69,222 |
Free Cash Flow | -5,088 | 13,803 | -14,582 | 15,199 |
Cash | 222,503 | 222,969 | 233,245 | 302,843 |
Basic Shares | 48,338 | 47,782 | 47,235 | 46,927 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $336,888 | $186,374 | $77,062 | $19,138 |
Gross Profit | 255,245 | 139,335 | 64,688 | 17,235 |
EBITDA | -48,972 | -136,490 | -122,411 | -65,386 |
EBIT | -72,601 | -147,319 | -126,092 | -66,361 |
Net Income | -87,942 | -163,415 | -135,665 | -83,988 |
Net Change In Cash | 336,888 | 186,374 | 77,062 | 19,138 |
Cost of Revenue | -3,349 | -10,745 | ||
Free Cash Flow | 9,332 | -91,053 | -120,414 | -151,782 |
Cash | 222,503 | 286,326 | 28,003 | 31,340 |
Basic Shares | 47,522 | 40,885 | 33,839 | 30,321 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$0.49 |
2024-09-30 | -$0.29 |
2024-06-30 | -$0.52 |
2024-03-31 | -$0.54 |
